Tara A Lavelle, PhD

Training + Education	Harvard Medical School; Postdoctoral Research Fellow in Comparative Effectiveness and Child Health, Child Health Evaluation and Research Unit, Division of General Pediatric, University of Michigan Medical School (2012-2013)
Gender	Female
Accepted Insurances	View Accepted Insurances at Tufts Medical Center

1. Lavelle TA, Weinstein MC, Newhouse JP, Munir K, Kuhlthau KA, Prosser LA. Economic Burden of Childhood Autism Spectrum Disorders. Pediatrics. 2014 February 10; 133(3): 520-529. PMID: 24515505

2. Lavelle TA, Wittenberg E, Lamarand K, Prosser LA: Variation in the spillover effects of illness on parents, spouses, and children of the chronically ill. Applied health economics and health policy 2014, 12(2):117-124. PMCID: PMC4307398

3. Lavelle TA, Uyeki TM, Prosser LA. Cost-effectiveness of Oseltamivir Treatment for Children with Uncomplicated Seasonal Influenza. J Pediatr. 2012;160(1):67-73. PMID: 21917267

4. Cohen DJ, Lavelle TA, Van Hout B, Li H, Lei Y, Robertus K, Pinto D, Mahoney EM, McGarry TF, Lucas SK, Horwitz PA, Henry CA, Serruys PW, Mohr FW, Kappetein AP. Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or 3-vessel coronary artery disease: One-year results from the SYNTAX trial. Catheter Cardiovasc Interv. 2012 Feb 1;79(2):198-209. PMID: 21542113

5. Lavelle TA, Meltzer MI, Gebremariam A, Lamarand K, Fiore A, Prosser LA. Community-based Values for 2009 Pandemic Influenza A H1N1 Illnesses and Vaccination-Related Adverse Events. PLoS One. 2011;6(12):e27777. PMCID: PMC3242758 Prosser LA, Lavelle TA, Fiore A, Bridges C, Reed C, Jain, S, Dunham K, Meltzer M. Cost-effectiveness of 2009 Pandemic Influenza A(H1N1) Vaccination in the United States. PLoS One. 2011;6(7):e22308. PMCID: PMC3146485

6. Mahoney EM, Greenberg D, Lavelle TA, Natarajan A, Berezin R, Ishak KJ, Caro JJ, Yadav JS, Gray WA, Wholey MH, Cohen DJ. Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trial. Catheter Cardiovasc Interv. 2011 Mar 1;77(4):463-72. PMID: 21351220

7. Reynolds MR, Lavelle T, Essebag V, Cohen DJ, Zimetbaum P. Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study. American Heart Journal 2006 Dec;152(6):1097-103. PMCID: PMC1820843

Tara Lavelle is an Assistant Professor at the Tufts Medical Center Institute for Clinical Research and Health Policy Studies and an Investigator at the Center for the Evaluation of Value and Risk in Health. Her research addresses a range of topics related to the cost and value of health care services delivered in the United States. Dr. Lavelle is particularly interested in advancing the use of comparative and cost-effectiveness research in vulnerable populations, including children. Previous work includes the development of novel methods for evaluating health and economic outcomes of childhood illness, and assessing preference-based quality of life outcomes in caregivers.

Dr. Lavelle earned her PhD in Health Policy with a concentration in Decision Science from Harvard University in 2012 and was previously a postdoctoral research fellow in the Child Health Evaluation and Research Unit in the Division of General Pediatrics at the University of Michigan.

Society for Medical Decision Making (2006-present)
Academy Health (2015- present)

Phone: 617-636-8793
Fax: 617-636-8628